Pharma: Other News To Note
Wednesday, October 23, 2013
• Samsung Biologics, of Seoul, South Korea, and Roche AG, of Basel, Switzerland, said they entered a long-term strategic manufacturing agreement under which Samsung will manufacture Roche’s commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.